[HTML][HTML] The impact of inappropriate use of short acting beta agonists in asthma

JM FitzGerald, H Tavakoli, LD Lynd, K Al Efraij… - Respiratory …, 2017 - Elsevier
Background Inappropriate use of short-acting beta-agonists (SABA) has been associated
with increased morbidity and mortality in asthma. However, the extent and pattern of SABA …

[HTML][HTML] The impact of inappropriate use of short acting beta agonists in asthma

JM FitzGerald, H Tavakoli, LD Lynd… - Respiratory …, 2017 - resmedjournal.com
Background Inappropriate use of short-acting beta-agonists (SABA) has been associated
with increased morbidity and mortality in asthma. However, the extent and pattern of SABA …

The impact of inappropriate use of short acting beta agonists in asthma

JM FitzGerald, H Tavakoli, LD Lynd… - Respiratory …, 2017 - pubmed.ncbi.nlm.nih.gov
Background Inappropriate use of short-acting beta-agonists (SABA) has been associated
with increased morbidity and mortality in asthma. However, the extent and pattern of SABA …

The impact of inappropriate use of short acting beta agonists in asthma.

JM FitzGerald, H Tavakoli, LD Lynd, K Al Efraij… - Respiratory …, 2017 - europepmc.org
Background Inappropriate use of short-acting beta-agonists (SABA) has been associated
with increased morbidity and mortality in asthma. However, the extent and pattern of SABA …